Authors' Affiliations: Departments of Pediatrics and Surgical Oncology; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center; and UTMD Graduate School of Biomedical Sciences, Houston, Texas.
Cancer Res. 2014 Mar 15;74(6):1645-50. doi: 10.1158/0008-5472.CAN-13-1739. Epub 2014 Jan 21.
To date, no specific marker exists for the detection of circulating tumor cells (CTC) from different types of sarcomas, though tools are available for detection of CTCs in peripheral blood of patients with cancer for epithelial cancers. Here, we report cell-surface vimentin (CSV) as an exclusive marker on sarcoma CTC regardless of the tissue origin of the sarcoma as detected by a novel monoclonal antibody. Utilizing CSV as a probe, we isolated and enumerated sarcoma CTCs with high sensitivity and specificity from the blood of patients bearing different types of sarcoma, validating their phenotype by single cell genomic amplification, mutation detection, and FISH. Our results establish the first universal and specific CTC marker described for enumerating CTCs from different types of sarcoma, thereby providing a key prognosis tool to monitor cancer metastasis and relapse.
迄今为止,尽管已经有工具可用于检测癌症患者外周血中的循环肿瘤细胞(CTC),但针对不同类型肉瘤的 CTC 检测仍然没有特异性标志物。在这里,我们报告了一种新型单克隆抗体,将细胞表面波形蛋白(CSV)作为肉瘤 CTC 的独特标志物,而与肉瘤的组织来源无关。利用 CSV 作为探针,我们从不同类型肉瘤患者的血液中分离并高灵敏度和特异性地计数了肉瘤 CTC,通过单细胞基因组扩增、突变检测和 FISH 验证了它们的表型。我们的研究结果确立了第一个用于从不同类型肉瘤中计数 CTC 的通用且特异的 CTC 标志物,从而为监测癌症转移和复发提供了一个关键的预后工具。